ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Prognostic value of KRAS exon 2 gene mutations in stage III colon cancer: Post hoc analyses of the PETACC8 trial.
Journal of Clinical Oncology
◽
10.1200/jco.2014.32.15_suppl.3549
◽
2014
◽
Vol 32
(15_suppl)
◽
pp. 3549-3549
Author(s):
Julien Taïeb
◽
Jean-François Emile
◽
Karine Le Malicot
◽
Aziz Zaanan
◽
Josep Tabernero
◽
...
Keyword(s):
Colon Cancer
◽
Prognostic Value
◽
Gene Mutations
◽
Stage Iii
◽
Exon 2
◽
Stage Iii Colon Cancer
◽
Post Hoc
◽
Kras Exon
Download Full-text
Related Documents
Cited By
References
Prognostic value and relation with adjuvant treatment duration of ctDNA in stage III colon cancer: a post-hoc analysis of the PRODIGE-GERCOR IDEA-France trial
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-21-0271
◽
2021
◽
pp. clincanres.0271.2021
Author(s):
Julien Taieb
◽
Valerie Taly
◽
Julie Henriques
◽
Camille Bourreau
◽
Laurent Mineur
◽
...
Keyword(s):
Colon Cancer
◽
Adjuvant Treatment
◽
Treatment Duration
◽
Prognostic Value
◽
Stage Iii
◽
Post Hoc Analysis
◽
Stage Iii Colon Cancer
◽
Post Hoc
Download Full-text
Prognostic Value of KRAS Mutations in Stage III Colon Cancer: Post-Hoc Analyses of the Petacc8 Phase III Trial
Annals of Oncology
◽
10.1093/annonc/mdu193.24
◽
2014
◽
Vol 25
◽
pp. ii115
Author(s):
J. Taieb
◽
J.F. Emile
◽
K. Le Malicot
◽
A. Zaanan
◽
J. Tabernero
◽
...
Keyword(s):
Colon Cancer
◽
Prognostic Value
◽
Phase Iii
◽
Stage Iii
◽
Kras Mutations
◽
Phase Iii Trial
◽
Stage Iii Colon Cancer
◽
Post Hoc
Download Full-text
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset
Annals of Oncology
◽
10.1093/annonc/mdu464
◽
2014
◽
Vol 25
(12)
◽
pp. 2378-2385
◽
Cited By ~ 55
Author(s):
H. Blons
◽
J.F. Emile
◽
K. Le Malicot
◽
C. Julié
◽
A. Zaanan
◽
...
Keyword(s):
Colon Cancer
◽
Prognostic Value
◽
Phase Iii
◽
Stage Iii
◽
Kras Mutations
◽
Phase Iii Trial
◽
Post Hoc Analysis
◽
Stage Iii Colon Cancer
◽
Post Hoc
Download Full-text
Prognostic Value of Kras Mutations in Stage III Colon Cancer: Post-Hoc Analyses of the Petacc8 Phase III Trial
Annals of Oncology
◽
10.1093/annonc/mdu333.74
◽
2014
◽
Vol 25
◽
pp. iv196
Author(s):
H. Blons
◽
J. Emile
◽
K. Le Malicot
◽
A. Zaanan
◽
J. Tabernero
◽
...
Keyword(s):
Colon Cancer
◽
Prognostic Value
◽
Phase Iii
◽
Stage Iii
◽
Kras Mutations
◽
Phase Iii Trial
◽
Stage Iii Colon Cancer
◽
Post Hoc
Download Full-text
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset
Annals of Oncology
◽
10.1093/annonc/mdv070
◽
2015
◽
Vol 26
(4)
◽
pp. 822-825
Author(s):
Josef Thaler
◽
Richard Greil
◽
Johannes Gaenzer
◽
Wolfgang Eisterer
◽
Joerg Tschmelitsch
◽
...
Keyword(s):
Colon Cancer
◽
Prognostic Value
◽
Phase Iii
◽
Stage Iii
◽
Kras Mutations
◽
Phase Iii Trial
◽
Post Hoc Analysis
◽
Stage Iii Colon Cancer
◽
Post Hoc
Download Full-text
2167 Microsatellite status predicts BRAF V600E and KRAS exon 2 mutations prognostic value in stage III colon cancers (CC) patients treated with adjuvant FOLFOX +/- cetuximab. A post-hoc analysis of the PETACC8 trial
European Journal of Cancer
◽
10.1016/s0959-8049(16)31087-5
◽
2015
◽
Vol 51
◽
pp. S389
Author(s):
J. Taieb
◽
A. Zaanan
◽
K. Le Malicot
◽
C. Julie
◽
H. Blons
◽
...
Keyword(s):
Prognostic Value
◽
Braf V600e
◽
Stage Iii
◽
Exon 2
◽
Post Hoc Analysis
◽
Colon Cancers
◽
Post Hoc
◽
Kras Exon
Download Full-text
Impact of laparoscopy on oncological outcomes after colectomy for stage III colon cancer: A post-hoc multivariate analysis from PETACC8 European randomized clinical trial
Digestive and Liver Disease
◽
10.1016/j.dld.2021.05.012
◽
2021
◽
Cited By ~ 1
Author(s):
Thibault Voron
◽
Mehdi Karoui
◽
Réa LoDico
◽
Karine Le Malicot
◽
Eloy Espin
◽
...
Keyword(s):
Clinical Trial
◽
Colon Cancer
◽
Multivariate Analysis
◽
Randomized Clinical Trial
◽
Stage Iii
◽
Stage Iii Colon Cancer
◽
Oncological Outcomes
◽
Post Hoc
Download Full-text
Prognostic value of BRAF V600E and KRAS exon 2 mutations in microsatellite stable (MSS), stage III colon cancers (CC) from patients (pts) treated with adjuvant FOLFOX+/- cetuximab: A pooled analysis of 3934 pts from the PETACC8 and N0147 trials.
Journal of Clinical Oncology
◽
10.1200/jco.2015.33.15_suppl.3507
◽
2015
◽
Vol 33
(15_suppl)
◽
pp. 3507-3507
◽
Cited By ~ 5
Author(s):
Julien Taieb
◽
Karine Le Malicot
◽
Frederique Madeleine Penault-Llorca
◽
Olivier Bouche
◽
Qian Shi
◽
...
Keyword(s):
Prognostic Value
◽
Pooled Analysis
◽
Braf V600e
◽
Stage Iii
◽
Exon 2
◽
Colon Cancers
◽
Kras Exon
Download Full-text
P-36 Prognostic value of tumor laterality and recurrence risk in patients with stage III colon cancer treated with adjuvant chemotherapy
Annals of Oncology
◽
10.1016/j.annonc.2020.04.118
◽
2020
◽
Vol 31
◽
pp. S101
Author(s):
A. Monteiro
◽
T. Cunha Pereira
◽
R. Félix Soares
◽
F. Macedo
◽
J. Paulo
◽
...
Keyword(s):
Colon Cancer
◽
Adjuvant Chemotherapy
◽
Prognostic Value
◽
Recurrence Risk
◽
Stage Iii
◽
Stage Iii Colon Cancer
◽
Tumor Laterality
Download Full-text
Prognostic value of primary tumor location in stage III colon cancer is associated with RAS and BRAF mutational status.
Annals of Oncology
◽
10.1093/annonc/mdx262.014
◽
2017
◽
Vol 28
◽
pp. iii142
◽
Cited By ~ 1
Author(s):
Julien Taieb
◽
Raphael Kourie Hampig
◽
François Emile Jean
◽
Karine Le Malicot
◽
Ralyath Balogoun
◽
...
Keyword(s):
Colon Cancer
◽
Primary Tumor
◽
Prognostic Value
◽
Tumor Location
◽
Stage Iii
◽
Primary Tumor Location
◽
Stage Iii Colon Cancer
◽
Mutational Status
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close